CSF1R and Alzheimer disease: The main aims of the study are: 1) to evaluate changes in CSF levels of proteins which interact with CSF1R, 2) to measure changes in the activity or levels of affected brain microglial cells and 3) to identify biomarkers to track AD progression (Pharmaceutica, 2019).